Reported 1 day ago
KKR & Co. has acquired a 12% stake in Henry Schein Inc., the world's largest medical product distributor, aiming to enhance its operations. KKR will become the largest non-index fund shareholder and has an option to increase its stake to nearly 15%. Two KKR representatives will join Henry Schein’s board, along with a new independent director, to bolster expertise in finance and operations. This move follows an activist campaign pushing for company reform, as Henry Schein anticipates revenue growth for 2025.
Source: YAHOO